Anthem Biosciences balance sheet

As of Mar 2026

Total assets: ₹3,429cr
Shareholders' equity: ₹3,043cr
Total debt: ₹51.1cr
Cash and investments: ₹938cr

₹ crore except per share

Tap a line for its trend	FY26Mar 2026

Non-current assets
	780
	264
	2.5
	0.4
	342
	7.3
	3.1
	166
	519
	27.3
	32.7
	1,626
Current assets
	125
	666
	591
	273
	2.0
	0.3
	1,531
	147
	1,803
	3,429
Equity
	112
	2,930
	3,043
	3,043
Liabilities
	27.7
	16.3
	44.0
	16.4
	0.7
	61.1
	23.3
	75.2
	5.9
	104
	21.0
	37.3
	163
	326
	387
	3,429
Trade payables — MSME split
	8.9
	66.3

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

ANTHEM₹830.15

Anthem Biosciences Ltd.

· Pharma & Health

₹ CrorePeersSYNGENE DIVISLAB GLAXO AJANTPHARM IPCALAB ABBOTINDIA MEDANTA GLENMARKMcap ₹46,631 Cr

View

In ₹ Crore except Per Share As of	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	780.3	780.3
+ Capital Work-in-Progress	264.3	264.3
+ Investment Property	2.5	2.5
+ Other Intangibles	0.4	0.4
+ Non-current Investments	341.9	341.9
+ Long-term Loans	7.3	7.3
+ Trade Receivables — Non-current	3.1	3.1
+ Other Non-current Financial Assets	166.3	166.3
Non-current Financial Assets	518.5	518.5
+ Deferred Tax Assets	27.3	27.3
+ Other Non-current Assets	32.7	32.7
Total Non-current Assets	1,626.1	1,626.1
Current Assets
+ Inventories	124.5	124.5
+ Current Investments	665.6	665.6
+ Trade Receivables	590.6	590.6
+ Cash & Cash Equivalents	272.9	272.9
+ Other Bank Balances	2.0	2.0
+ Other Current Financial Assets	0.3	0.3
Current Financial Assets	1,531.4	1,531.4
+ Other Current Assets	147.3	147.3
Total Current Assets	1,803.1	1,803.1
Total Assets	3,429.3	3,429.3
Equity
+ Equity Share Capital	112.3	112.3
+ Other Equity / Reserves	2,930.2	2,930.2
Equity — Owners of Parent	3,042.5	3,042.5
Total Equity	3,042.5	3,042.5
Liabilities
+ Borrowings — Non-current	27.7	27.7
+ Other Non-current Financial Liab	16.3	16.3
Non-current Financial Liabilities	44.0	44.0
+ Provisions — Non-current	16.4	16.4
+ Other Non-current Liabilities	0.7	0.7
Non-current Liabilities	61.1	61.1
+ Borrowings — Current	23.3	23.3
+ Trade Payables	75.2	75.2
+ Other Current Financial Liab	5.9	5.9
Current Financial Liabilities	104.5	104.5
+ Provisions — Current	21.0	21.0
+ Current Tax Liabilities	37.3	37.3
+ Other Current Liabilities	163.0	163.0
Current Liabilities	325.7	325.7
Total Liabilities	386.8	386.8
Total Equity & Liabilities	3,429.3	3,429.3
Trade Payables — MSME split
+ Dues to Micro & Small — Current	8.9	8.9
+ Dues to Other Creditors — Current	66.3	66.3

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.